China Leads Strong AstraZeneca Emerging Markets Charge In Q1
Executive Summary
Despite a fall in overall revenue, emerging markets continued to perform strongly for AstraZeneca in the first quarter, becoming the UK group's single largest sales region globally, driven mainly by China.